2020-12-15 OMA Agenda - Board of Trustees

of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology 2018. 12. Hendricks EJ, Greenway FL, Westman EC, Gupta AK. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity (Silver Spring, Md) 2011; 19: 2351-2360. 13. Hendricks EJ, Srisurapanont M, Schmidt SL, Haggard M, Souter S, Mitchell CL , et al. Addiction potential of phentermine prescribed during long-term treatment of obesity. Int J Obes (Lond) 2014; 38: 292-298. 14. Bays H. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease. Expert review of cardiovascular therapy 2010; 8: 1777- 1801. 15. Ritchey ME, Harding A, Hunter S, Peterson C, Sager PT, Kowey PR , et al. Cardiovascular Safety During and After Use of Phentermine and Topiramate. The Journal of clinical endocrinology and metabolism 2019; 104: 513-522. 16. Ciemins E, Joshi V, Horn D, Nadglowski J, Ramasamy A, Cuddeback J. Measuring What Matters: Beyond Quality Performance Measures in Caring for Adults with Obesity. Popul Health Manag 2020. 17. U.S. Department of Justice. Drug Enforcement Administration. Diversion Control Division. COVID-19 Information Page https://www.deadiversion.usdoj.gov/coronavirus.html. (Accessed November 15 2020).

24